127 related articles for article (PubMed ID: 23090298)
1. [Plasmodium vivax malaria recurrence according to the use of primaquine: analysis of longitudinal descriptive studies].
Carmona-Fonseca J
Rev Bras Epidemiol; 2012 Sep; 15(3):488-503. PubMed ID: 23090298
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of alternative primaquine regimens to standard treatment in preventing relapses by Plasmodium vivax: A systematic review and meta-analysis.
Zuluaga-Idarraga LM; Tamayo Perez ME; Aguirre-Acevedo DC
Colomb Med (Cali); 2015 Dec; 46(4):183-91. PubMed ID: 26848199
[TBL] [Abstract][Full Text] [Related]
3. Primaquine treatment and relapse in Plasmodium vivax malaria.
Rishikesh K; Saravu K
Pathog Glob Health; 2016; 110(1):1-8. PubMed ID: 27077309
[TBL] [Abstract][Full Text] [Related]
4. A pilot randomized controlled trial to compare the effectiveness of two 14-day primaquine regimens for the radical cure of vivax malaria in South India.
Saravu K; Tellapragada C; Kulavalli S; Xavier W; Umakanth S; Brahmarouphu G; Srinivas NK; Channabasavaiah JP; Bava A; Saadi AV; Guddattu V; Satyamoorthy K; Bhat K
Malar J; 2018 Sep; 17(1):321. PubMed ID: 30176897
[TBL] [Abstract][Full Text] [Related]
5. Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: An observational and modeling study in Brazil.
Corder RM; de Lima ACP; Khoury DS; Docken SS; Davenport MP; Ferreira MU
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008526. PubMed ID: 32735631
[TBL] [Abstract][Full Text] [Related]
6. Recurrence in
Gandrala D; Gupta N; Lavu A; Nallapati VT; Guddattu V; Saravu K
F1000Res; 2022; 11():279. PubMed ID: 35464047
[No Abstract] [Full Text] [Related]
7. Primaquine and relapses of Plasmodium vivax. Meta analysis of controlled clinical trials.
Carmona Fonseca J
Rev Bras Epidemiol; 2015; 18(1):174-93. PubMed ID: 25651020
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Assessment of Primaquine for Radical Cure of
Kumar R; Guddattu V; Saravu K
Korean J Parasitol; 2016 Dec; 54(6):733-742. PubMed ID: 28095658
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India.
Rishikesh K; Kamath A; Hande MH; Vidyasagar S; Acharya RV; Acharya V; Belle J; Shastry AB; Saravu K
Malar J; 2015 Aug; 14():310. PubMed ID: 26259839
[TBL] [Abstract][Full Text] [Related]
10. A randomised trial of an eight-week, once weekly primaquine regimen to prevent relapse of plasmodium vivax in Northwest Frontier Province, Pakistan.
Leslie T; Mayan I; Mohammed N; Erasmus P; Kolaczinski J; Whitty CJ; Rowland M
PLoS One; 2008 Aug; 3(8):e2861. PubMed ID: 18682739
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India.
Saravu K; Kumar R; Ashok H; Kundapura P; Kamath V; Kamath A; Mukhopadhyay C
PLoS One; 2016; 11(6):e0157666. PubMed ID: 27315280
[TBL] [Abstract][Full Text] [Related]
12. Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India.
Yadav RS; Ghosh SK
J Parasitol; 2002 Oct; 88(5):1042-4. PubMed ID: 12435158
[TBL] [Abstract][Full Text] [Related]
13. Can primaquine therapy for vivax malaria be improved?
Baird JK; Rieckmann KH
Trends Parasitol; 2003 Mar; 19(3):115-20. PubMed ID: 12643993
[TBL] [Abstract][Full Text] [Related]
14. Estimating the Proportion of
Commons RJ; Simpson JA; Watson J; White NJ; Price RN
Am J Trop Med Hyg; 2020 Sep; 103(3):1094-1099. PubMed ID: 32524950
[No Abstract] [Full Text] [Related]
15. Interventions for promoting patients' adherence to 14-day primaquine treatment in a highly malaria-endemic township in Myanmar: a qualitative study among key stakeholders.
Win KM; Aung PL; Ring Z; Linn NYY; Kyaw MP; Nguitragool W; Cui L; Sattabongkot J; Lawpoolsri S
Malar J; 2023 Oct; 22(1):302. PubMed ID: 37814267
[TBL] [Abstract][Full Text] [Related]
16. Novel Insights into Plasmodium vivax Therapeutic Failure: CYP2D6 Activity and Time of Exposure to Malaria Modulate the Risk of Recurrence.
Silvino ACR; Kano FS; Costa MA; Fontes CJF; Soares IS; de Brito CFA; Carvalho LH; Sousa TN
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32122891
[No Abstract] [Full Text] [Related]
17. Single dose tafenoquine for preventing relapse in people with plasmodium vivax malaria-an updated meta-analysis.
Anjum MU; Naveed AK; Mahmood SN; Naveed OK
Travel Med Infect Dis; 2020; 36():101576. PubMed ID: 32036012
[TBL] [Abstract][Full Text] [Related]
18. Primaquine for preventing relapses in people with Plasmodium vivax malaria.
Galappaththy GN; Omari AA; Tharyan P
Cochrane Database Syst Rev; 2007 Jan; (1):CD004389. PubMed ID: 17253504
[TBL] [Abstract][Full Text] [Related]
19. Effect of weekly versus daily primaquine on Plasmodium vivax malaria recurrences: A real-life cohort study.
Brito-Sousa JD; Phanor J; Balieiro PCDS; Silva-Neto AV; Cordeiro JSM; Vitor-Silva S; Mendes M; Sampaio VS; Melo GC; Lacerda M; Monteiro W
Rev Soc Bras Med Trop; 2022; 55():e07382021. PubMed ID: 35522815
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.
Yeshiwondim AK; Tekle AH; Dengela DO; Yohannes AM; Teklehaimanot A
Acta Trop; 2010 Feb; 113(2):105-13. PubMed ID: 19835832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
